|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01833 PA GOODDOCTOR
Nominal 
22.200 +0.060 (+0.271%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 2,502,193 | 19.525% | 4,808,082 | 4,673,562 | 6,205,082 | 7,334,214 |
| Cost of Sales | (1,662,484) | 17.105% | (3,284,726) | (3,165,049) | (4,533,851) | (5,627,353) |
| Gross Profit | 839,709 | 24.623% | 1,523,356 | 1,508,513 | 1,671,231 | 1,706,861 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 1,359 | -- | 279 | 251 | (66,323) | (38,773) | |
| Profit / (Loss) before Taxation | 136,260 | 124.659% | 93,772 | (331,893) | (636,183) | (1,523,607) | |
| Taxation | (1,352) | 5778.261% | (5,450) | (2,965) | (3,410) | (15,792) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (744) | -81.311% | (6,894) | 12,264 | 3,535 | 1,216 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 134,164 | 136.838% | 81,428 | (322,594) | (636,058) | (1,538,183) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (60,033) | -41.395% | (182,557) | (255,193) | (257,939) | (299,631) |
| Depreciation & Amortisation | 37,584 | -28.451% | 96,257 | 160,779 | 190,178 | 206,940 |
| Directors' Emoluments | -- | -- | 16,766 | 20,990 | 26,808 | 28,309 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 7.000 | 40.000% | 8.000 | -30.000 | -59.000 | -139.000 |
| DPS (cts) | 887.327 | -- | 895.533 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 12676.098% | -- | 11194.164% | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.092 | (0.262) | (0.750) | (1.272) |
| NBV per share ($) | 4.490 | -- | 3.208 | 11.873 | 12.095 | 12.275 |
| Remarks: | Real time quote last updated: 05/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 134,164 |
| %Change | 136.838% |
| EPS / (LPS) | RMB 0.070 |
| NBV Per Share (¥) | RMB 4.490 |